Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ovulation Inhibition with Two 4-phasic EV/DNG Regimens
NCT00805415Phase 2Completed
- Sponsor
- Bayer
- Start
- Mar 2003
- Primary completion
- Feb 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, open-label trial of estradiol valerate + dienogest in contraception (2 arms), sponsored by Bayer. Primary endpoint: Proportion of subjects with a Hoogland score of 5-6 (luteinized unruptured follicle [LUF] or ovulation). Started Mar 2003; status: completed.
02
Drugs
estradiol valerate + dienogest
03
Conditions
contraception
Beyond the preview
Go deeper on NCT00805415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00805415.